IDH1 and glioblastoma: In the GBM group with high m6A scores, an immune tolerance phenotype characterized by mesenchymal tissue subtypes and IDH1 wild molecule subtypes, as well as high infiltration of immune cells and stromal cells was demonstrated (160).